I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| basal cell | 15 studies | 29% ± 10% | |
| fibroblast | 14 studies | 27% ± 10% | |
| plasmacytoid dendritic cell | 10 studies | 27% ± 8% | |
| plasma cell | 7 studies | 24% ± 9% | |
| conventional dendritic cell | 6 studies | 25% ± 6% | |
| goblet cell | 6 studies | 29% ± 10% | |
| mast cell | 5 studies | 20% ± 3% | |
| epithelial cell | 5 studies | 27% ± 10% | |
| non-classical monocyte | 4 studies | 25% ± 6% | |
| endothelial cell | 4 studies | 25% ± 3% | |
| erythrocyte | 4 studies | 33% ± 20% | |
| endothelial cell of vascular tree | 4 studies | 21% ± 3% | |
| natural killer cell | 4 studies | 20% ± 3% | |
| secretory cell | 3 studies | 20% ± 3% | |
| plasmablast | 3 studies | 34% ± 16% | |
| extravillous trophoblast | 3 studies | 21% ± 2% | |
| dendritic cell | 3 studies | 33% ± 8% | |
| serous secreting cell | 3 studies | 19% ± 2% | |
| macrophage | 3 studies | 21% ± 3% | |
| CD16-negative, CD56-bright natural killer cell, human | 3 studies | 20% ± 3% | |
| erythroblast | 3 studies | 38% ± 19% | |
| CD8-positive, alpha-beta T cell | 3 studies | 24% ± 6% |
